Publication | Open Access
Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance
98
Citations
30
References
2009
Year
Molecular PharmacologyMedicinal ChemistryPotent Reversal AgentsDrug Resistance AnalysisMedicineImmunologyMultidrug ResistancePharmacotherapyAnti-cancer AgentPharmacologyDrug DiscoveryDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1